Novotech cooperates with Endpoints News to host a special webinar series.
The leading Asia-Pacific biotech specialist CRO Novotech is again collaborating with the prestigious biotech and pharma news platform Endpoints News. The latest webinar, which took place on June 14, focused on how to advance oncology clinical trials in the Asia-Pacific which is currently attracting 10,000 oncology studies (GlobalData).
The webinar was led by Endpoints News Publisher Arsalan Arif. Participants included leading experts from the Asia-Pacific region and a US biotech sponsor.
Webinar title: Advancing Oncology Trials in Asia-Pacific
Broadcast time: July 14th 2PM EST
Access the recording here: https://vimeo.com/438358469
Check previous webinars below:
There are currently about 10,000 oncology clinical trials, either ongoing or planned, in Asia-Pacific and about 50% of all industry-sponsored oncology trials in 2019 globally have an Asia-Pacific component (GlobalData).
Meanwhile, the number of industry-sponsored oncology trials initiated in Asia-Pacific has grown by over 10% on average annually between 2017 and 2019 (GlobalData).
About Novotech – https://novotech-cro.com
For RFP enquiries: Please fill out the form available at https://novotech-cro.com/talk-to-an-expert
Read more on ACN Newswire
AU: +61 2 8218 2144
USA: +1 415 951 3228
Asia: +65 3159 3427